Previous scientific data suggest that adjuvant vitamin E therapy provides significant biochemical (ALT and AST levels) and histological abnormalities (hepatic steatosis and lobular inflammation) improvements in adult patients with NAFLD, but further studies are needed to evaluate the long-term safety and efficacy of proposed treatments [38,40]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.